CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-30 | Bonita David P Director | Conversion | +42,614 | 42,614 | ||
| 2021-03-30 | Bonita David P Director | Purchase | +375,000 | $16.00 | $6.0M | 1,845,872 |
| 2021-03-30 | Bonita David P Director | Purchase | +48,400 | $16.00 | $774K | 91,014 |
| 2021-03-30 | Bonita David P Director | Conversion | +5,429,023 | 5,429,023 | ||
| 2021-03-30 | Bonita David P Director | Conversion | +157,288 | 157,288 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A Preferred Stock | −2,034,708 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A Preferred Stock | −551,259 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A-1 Preferred Stock | −2,411,260 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A-1 Preferred Stock | −653,277 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −983,054 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −266,337 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −157,288 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −42,614 | 0 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +1,470,872 | 1,470,872 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +42,614 | 42,614 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Purchase | +375,000 | $16.00 | $6.0M | 1,845,872 |
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Purchase | +48,400 | $16.00 | $774K | 91,014 |
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +5,429,023 | 5,429,023 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +157,288 | 157,288 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion · Series A Preferred Stock | −2,034,708 | 0 |
Page 8 of 12 · 222 trades